1-(4-Amino-6,7-Dimethoxy-2-Quinazolinyl)-4-{(Tetnaphydro-2-Furanyl)Carbonyl}Piperazine 1-(4-氨基-6,7-二甲氧基-2-喹唑啉基)-4-[(四氢呋喃-2-甲酰基)哌嗪

CAS 63590-64-7 MFCD00072144

化学结构图

63590-64-7
SMILES: COC1=CC2C(N)=NC(=NC=2C=C1OC)N1CCN(CC1)C(=O)C1CCCO1

化学属性

Mol. FormulaC19H25N5O4
Mol. Weight387.438

别名和识别编码

Chemical Name1-(4-Amino-6,7-Dimethoxy-2-Quinazolinyl)-4-{(Tetnaphydro-2-Furanyl)Carbonyl}Piperazine
Chemical Name Translation1-(4-氨基-6,7-二甲氧基-2-喹唑啉基)-4-[(四氢呋喃-2-甲酰基)哌嗪
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [2]. Vincent J, et al. Pharmacological tolerance to alpha 1-adrenergic receptor antagonism mediated by terazosin in humans. J Clin Invest. 1992 Nov;90(5):1763-8.
  • [3]. Ju M, et al. Efficacy of combination terazosin and nifedipine therapy in postoperative treatment of distal ureteral stones after transurethral ureteroscopic lithotripsy. J Int Med Res. 2020 Apr;48(4):300060520904851.
  • [1]. Michel MC, et al. Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned alpha 1-adrenoceptor subtypes and in human prostate. J Auton Pharmacol. 1996 Feb;16(1):21-8.
  • [1]. Michel MC, et al. Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned alpha 1-adrenoceptor subtypes and in human prostate. J Auton Pharmacol. 1996 Feb;16(1):21-8.
  • [2]. Vincent J, et al. Pharmacological tolerance to alpha 1-adrenergic receptor antagonism mediated by terazosin in humans. J Clin Invest. 1992 Nov;90(5):1763-8.
  • [3].

系列性分类

  1. Medical Research Areas
  2. GPCR & G Protein
  3. Adrenergic Receptor  (肾上腺素能受体)

相关产品推荐